Package 0069-0505-02

Brand: ngenla

Generic: somatrogon-ghla
NDC Package

Package Facts

Identity

Package NDC 0069-0505-02
Digits Only 0069050502
Product NDC 0069-0505
Product ID 0069-0505_6e73b67b-0cab-4f0d-95b9-67579f00aa7f
Description

1 CARTRIDGE in 1 CARTON (0069-0505-02) / 1.2 mL in 1 CARTRIDGE (0069-0505-01)

Marketing

Marketing Status
Marketed Since 2023-07-31
Brand ngenla
Generic somatrogon-ghla
Sample Package No

Linked Drug Pages (1)

Ngenla ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["SUBCUTANEOUS"], "spl_id": "6e73b67b-0cab-4f0d-95b9-67579f00aa7f", "openfda": {"unii": ["6D848RA61B"], "rxcui": ["2644517", "2644523", "2644526", "2644529"], "spl_set_id": ["06dce529-b741-4a1b-8842-3ad77be6e308"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 CARTRIDGE in 1 CARTON (0069-0505-02)  / 1.2 mL in 1 CARTRIDGE (0069-0505-01)", "package_ndc": "0069-0505-02", "marketing_start_date": "20230731"}], "brand_name": "Ngenla", "product_id": "0069-0505_6e73b67b-0cab-4f0d-95b9-67579f00aa7f", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["11-beta Hydroxysteroid Dehydrogenase Type 1 Inhibitors [MoA]", "Human Growth Hormone [CS]", "Recombinant Human Growth Hormone [EPC]"], "product_ndc": "0069-0505", "generic_name": "somatrogon-ghla", "labeler_name": "Pfizer Laboratories Div Pfizer Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ngenla", "active_ingredients": [{"name": "SOMATROGON", "strength": "24 mg/1.2mL"}], "application_number": "BLA761184", "marketing_category": "BLA", "marketing_start_date": "20230731", "listing_expiration_date": "20261231"}